Supplements11 min read

Iron Bisglycinate: Effectiveness, Indications and Precautions

Iron bisglycinate may be better tolerated in some trials, particularly during pregnancy. The real question remains the diagnosis: a documented deficiency, an identified cause, the elemental iron dose, and interactions.

By Claire Mercier

Updated 09/28/2026

4Sources

6Validated claims

LimitedDominant evidence

AT A GLANCE

Before you dive in.

Explore the article

Iron bisglycinate is marketed as a form that's better tolerated and better absorbed than classic iron salts. That claim has some truth to it, but it doesn't answer the more important question: do you actually need iron, and is the chosen form suited to your situation? Bisglycinate is an iron chelate bound to two glycine molecules. Studies suggest a benefit in certain contexts, especially when digestive discomfort complicates taking iron, but they don't justify systematic self-supplementation or a one-size-fits-all dose.

1. What form are we talking about? Iron bisglycinate, often called chelated iron or amino acid-chelated iron, combines iron with glycine. It should not be confused with magnesium bisglycinate. On the label, check above all the amount of elemental iron: the total weight of the compound or the capsule doesn't let you compare products. Sulfate, fumarate and gluconate are commonly used iron salts. Bisglycinate is another chemical form, not a separate treatment category. Product quality, the elemental iron dose, consistency of intake, and the initial diagnosis matter just as much as the name of the form.

2. How effective is it against deficiency? The best synthesis available is a systematic review and meta-analysis published in 2023. It included 17 randomized trials comparing bisglycinate with other iron supplements, after at least four weeks of use. In pregnant women, over periods of 4 to 20 weeks, bisglycinate was associated with a higher hemoglobin concentration than other supplements (standardized mean difference of 0.54; 95% confidence interval: 0.15–0.94) and with fewer reported digestive events (rate ratio 0.36; 95% CI: 0.17–0.76). The trend for ferritin was not statistically significant. In children, the meta-analysis found no significant difference in hemoglobin or ferritin.

Evidence level

The signal is favorable in pregnant women, but the trials are heterogeneous and the data remain limited in men, non-pregnant women, and children. This review doesn't establish the optimal dose, frequency, or duration. A randomized trial in 200 schoolchildren with low iron stores but no anemia compared 30 mg of elemental iron per day as sulfate or bisglycinate for 12 weeks. Ferritin increased in both groups. A difference favoring bisglycinate appeared six months later, but the probability of low stores didn't differ by form, and hemoglobin didn't change significantly. This result illustrates why a single biological marker isn't enough to declare general clinical superiority. A small double-blind trial in anemic children compared bisglycinate with iron polymaltose for 45 days, at 3 mg/kg/day in each group. Both treatments raised hemoglobin; bisglycinate also raised ferritin in this sample. The study doesn't allow this protocol to be extrapolated to adults or to replace a pediatric prescription.

3. Better absorbed: true, but under what conditions? Absorption studies have observed higher absorption of bisglycinate compared with sulfate in certain corn-based meals. This documents a difference in bioavailability in a specific context; it is not proof that it will always be more effective in everyday life. Absorption depends on the state of the body's stores, on hepcidin, on the meal, on inhibitors, and on the exact form of the product. Heme iron from animal foods and non-heme iron from plants do not behave the same way. Vitamin C can promote the absorption of non-heme iron; phytates from grains and legumes, certain polyphenols in tea and coffee, and potentially calcium, can reduce it. These dietary effects are not absolute and are softened by the overall diet. Bisglycinate therefore doesn't allow you to ignore the meal or concurrent treatments.

4. What are the relevant indications? The relevant indication is a confirmed iron deficiency, with or without anemia, once a health professional has assessed the results and the context. Ferritin is a marker of iron stores, but its interpretation depends notably on inflammation; hemoglobin alone isn't enough to explain a deficiency. Depending on the situation, the workup can be expanded and the cause investigated: heavy menstrual losses, pregnancy, growth, insufficient intake, malabsorption, digestive bleeding, or chronic disease. For someone who tolerates an iron salt poorly, bisglycinate can be discussed as an option. The meta-analysis suggests fewer digestive effects in pregnant women, but this doesn't guarantee the absence of constipation, nausea, abdominal pain, or diarrhea. Better tolerance can improve consistency of use; it doesn't turn a supplement into an appropriate treatment for any kind of fatigue.

5. Dose, duration and reading the label

There is no universal bisglycinate dose. Trials have used different amounts and durations, and the 2023 review was not designed to determine the best regimen. Don't transpose the dose from a pediatric, prenatal, or therapeutic trial to your own situation. Compare elemental iron, not the weight of the chelate. Add up your sources: a multivitamin, a "hair" supplement, a prenatal formula, and a separate bisglycinate product can all add up. A professional can specify the target, the follow-up testing schedule, and the duration based on the workup. Improvement in symptoms doesn't replace biological monitoring. EFSA has not established a tolerable upper intake level for iron due to insufficient data. It has nonetheless proposed a safe level for total intake of 40 mg per day in adults, including during pregnancy and breastfeeding, outside of medically supervised treatment for iron-deficiency anemia. This level is not a supplementation recommendation and does not apply as a simple rule to a medically supervised prescription.

6. Precautions, interactions and at-risk populations

Excess iron can cause digestive effects and become toxic. Highly dosed supplements can cause stomach discomfort, constipation, nausea, abdominal pain, vomiting, or diarrhea. Iron can also reduce zinc absorption starting at around 25 mg in certain contexts. Keep any product out of reach of children: accidental ingestion of large amounts can be serious. Iron interacts with certain medications. It can reduce the absorption of levothyroxine; package inserts often recommend not taking it within four hours of an iron supplement. It can also interact with levodopa. Proton pump inhibitors, such as omeprazole, can reduce iron absorption by lowering stomach acidity. Calcium can also interfere; spacing out doses is sometimes advised. Ask a pharmacist or doctor before changing a treatment. Supplementation without a documented deficiency calls for particular caution in cases of hemochromatosis, liver disease, repeated transfusions, inflammatory disease, or digestive disorders. Pregnancy, breastfeeding, childhood and adolescence warrant professional guidance, even though bisglycinate is found in mainstream consumer products.

7. How to decide without being guided by marketing? Start with the clinical question: is a deficiency confirmed, and has its cause been explored? Next, check the elemental iron per serving, other sources of iron, and the excipients. If a salt is poorly tolerated, discuss another form rather than raising the dose on your own. Finally, define the biological follow-up and the point at which the product should be stopped together with the professional. Dietary choices remain useful, but they don't always quickly correct a confirmed anemia. Iron-rich foods can fit into an overall strategy; they don't justify stopping a necessary treatment. Conversely, a capsule doesn't compensate for persistent blood loss or an unidentified absorption problem.

08FAQ

01Is bisglycinate always better than sulfate? No. Some studies show better tolerance or absorption in certain contexts, but superiority isn't established for all populations and all outcomes.

02Can it be taken without a blood test? It's best to avoid targeted supplementation without a documented deficiency. Fatigue has many causes, and excess iron isn't harmless.

03Does bisglycinate cause less constipation? The available review suggests fewer digestive events in pregnant women, without guaranteeing the absence of effects in every individual.

04Can it be taken with levothyroxine? Iron can reduce its absorption. Ask the professional managing your treatment how to space out the doses; package inserts often mention four hours.

05Is the 40 mg limit a dose to aim for? No. EFSA refers to a safe level for total intake in adults, not a supplementation target, and it excludes medically supervised treatment for iron-deficiency anemia.

Sources

Peer-reviewed studies and institutional references used for this article.

1EFSA (European Food Safety Authority)· 2024
Official guidelineEstablished
safe level for total iron intake
View source
2Fischer et al., meta-analysis· 2023
Meta-analysisLimited
17 randomized trials comparing bisglycinate with other iron supplements · 17 participants
View source
3Duque et al., randomized trial· 2014
Randomized controlled trialLimited
200 schoolchildren with low iron stores and no anemia · 200 participants
View source
4Bovell-Benjamin et al.· 2000
Randomized controlled trialLimited
compared absorption in a corn-based meal
View source

Before you dive in.

5. Dose, duration and reading the label

6. Precautions, interactions and at-risk populations

08FAQ

Sources

Claire Mercier

Comments0 comments

Related reading

Potassium supplements: needs, sources and the risk of hyperkalemia

Copper Supplements: Needs, Deficiency and the Risks of Excess

Vitamin A supplements: forms, needs, risks and pregnancy